Pancreatic Cancer Research

ResearcherJiaxing UniversityNo recent work listed

Haokai Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1397-343X; OpenAlex author ID A5035396655. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers

Papers 4

  1. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. First author DOI 10.1080/21655979.2021.1934243↗
  2. CXCL10 Expression in Tumor Tissues and is An Independent Prognostic Indicator of Pancreatic Cancer First author DOI 10.21203/rs.3.rs-966327/v1↗
  3. Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy. Co-author DOI 10.3892/etm.2021.10574↗
  4. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas. Co-author DOI 10.3892/mmr.2020.11504↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengxiang Zhong · 4 shared papers, 2020–2021 · strength 0.58
  2. Lingyu Hu · 3 shared papers, 2021 · strength 0.46
  3. Xiaoguang Wang · 3 shared papers, 2020–2021 · strength 0.39
  4. Fei Chen · 2 shared papers, 2020–2021 · strength 0.25
  5. Wei Chen · 2 shared papers, 2020–2021 · strength 0.25
  6. Zhengwei Song · 2 shared papers, 2020–2021 · strength 0.25
  7. Bin Wu · 1 shared paper, 2021 · strength 0.19
  8. Bin Yan Wu · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.